PRICE T ROWE ASSOCIATES INC /MD/ - CEREVEL THERAPEUTICS HLDNG I ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2021$3,182,000
+221.7%
223,127
-4.8%
0.00%
Q1 2021$989,000
-25.3%
234,2660.0%0.00%
Q4 2020$1,324,000234,2660.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q3 2021
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 72,466$409,0000.22%
Altium Capital Management LP 64,666$365,0000.14%
Nantahala Capital Management 283,332$4,307,0000.13%
Governors Lane LP 196,034$1,108,0000.09%
SPHERA FUNDS MANAGEMENT LTD. 166,332$940,0000.08%
Monashee Investment Management LLC 99,998$565,0000.08%
Context Capital Management, LLC 85,967$486,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 75,400$1,250,0000.05%
Maven Securities LTD 56,667$338,0000.03%
Walleye Capital LLC 70,649$399,0000.03%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders